Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 10.04.2026 FDNI.LN IE00BT9PVG14 425,002.00 USD 7,725,591.41 18.178 ...
-
At Semafor World Economy Lumen CEO Kate Johnson Issues Open Letter to CEOs: “Is Your Network AI-Ready?”—Calling for AI-Ready Network Modernization
DENVER--(BUSINESS WIRE)--Timed to coincide with Semafor World Economy 2026, taking place April 13-17 in Washington, DC, Lumen Technologies’ (“Lumen”) (NYSE: LUMN) CEO Kate Johnson issued an open letter to CEOs asking, “Is your network AI-ready?” The letter points to the urgent need to upgrade networking infrastructure to support AI aspirations. Johnson will expand on the topic during a fireside chat that is part of a session on “AI’s Next Chapter,” which begins at 9 a.m. ET on Tuesday, April 14...
-
Mosaic Service Partners Selects Zuper as Part of Its Core Operating Technology Platform to Support National Expansion
SEATTLE--(BUSINESS WIRE)--Zuper announced that Mosaic Service Partners has selected Zuper as part of its core operating technology platform to support scalable operations....
-
Ameresco Collaborates with Miami-Dade County on Energy Savings Project to Deliver Solar and Efficiency Upgrades
FRAMINGHAM, Mass. & MIAMI--(BUSINESS WIRE)--Ameresco Delivers Solar and Lighting Upgrades for Miami-Dade...
-
SchoolsFirst Federal Credit Union Ranked #1 in Member Satisfaction by JD Power for the Second Consecutive Year
TUSTIN, Calif.--(BUSINESS WIRE)--For the second year in a row, SchoolsFirst Federal Credit Union has earned the top ranking in the JD Power U.S. Credit Union Satisfaction StudySM, the most widely recognized benchmark for members' experience in the financial services industry. SchoolsFirst FCU ranked #1 for overall satisfaction, a result driven entirely by its Members, California’s school employees and their families. The distinction reflects ratings across multiple dimensions, including trust,...
-
TrueBlue to Appoint New Independent Director
TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue, Inc. (NYSE: TBI) (“TrueBlue” or the “Company”), a leading provider of specialized workforce solutions, today announced that its Board of Directors (the “Board”) will appoint a new independent director to the Board by no later than September 30, 2026. In accordance with a cooperation agreement (the “Agreement”) TrueBlue has entered into with EHS Investments, the new independent director will be mutually agreed upon by the Company and EHS. “The Board cont...
-
Tanger Increases Dividend by 7%
GREENSBORO, N.C.--(BUSINESS WIRE)--Tanger® (NYSE: SKT), a leading owner and operator of outlet and other open-air retail shopping destinations, announced today that its Board of Directors approved a 6.8% increase in the dividend on its common shares from $1.17 to $1.25 per share on an annualized basis. Simultaneously, the Board of Directors declared a quarterly cash dividend of $0.3125 per share, payable on May 15, 2026 to common shareholders of record on April 30, 2026. “Our dividend increase...
-
Quiver Bioscience Receives Strategic Investment From the Porta Family to Advance UBE3A ASO Therapeutic Program for Dup15q Syndrome
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience receives strategic investment from the Porta family to advance its ASO program for Dup15q syndrome....
-
nLIGHT to Announce First Quarter 2026 Financial Results on May 7th
CAMAS, Wash.--(BUSINESS WIRE)--nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications, announced that it will release its financial results for the first quarter of 2026 after the financial markets close on Thursday, May 7, 2026. A webcast to discuss the first quarter results will be held on Thursday, May 7, 2026, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). The audio webcast will...
-
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in one of three expansion cohorts in the Phase 1 trial evaluating VIR-5500, a prostate-specific membrane antigen (PSMA)-targeted, PRO-XTEN® dual-masked T-cell engager (TCE) for metastatic prostate cancer (NCT05997615). The Phase 1 trial is measuring the safety and efficacy of VIR-5500 monotherapy in late-line mCRPC, and of VIR-5500 in combination with an androgen receptor...